Inari Medical Inc
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-… Read more
Inari Medical Inc (NARI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2024: 0.006x
Based on the latest financial reports, Inari Medical Inc (NARI) has a cash flow conversion efficiency ratio of 0.006x as of September 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.71 Million) by net assets ($434.76 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Inari Medical Inc - Cash Flow Conversion Efficiency Trend (2018–2023)
This chart illustrates how Inari Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Inari Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Inari Medical Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Samsung SDS Co Ltd
KO:018260
|
0.033x |
|
3SBio Inc
F:83B
|
0.031x |
|
Ho Chi Minh City Development Joint Stock Commercial Bank
VN:HDB
|
0.622x |
|
SFS Group AG
SW:SFSN
|
0.119x |
|
Atmus Filtration Technologies Inc.
NYSE:ATMU
|
0.217x |
|
Ono Pharmaceutical Co. Ltd
PINK:OPHLF
|
0.038x |
|
Mueller Water Products
NYSE:MWA
|
0.060x |
|
Grand Canyon Education Inc
NASDAQ:LOPE
|
0.175x |
Annual Cash Flow Conversion Efficiency for Inari Medical Inc (2018–2023)
The table below shows the annual cash flow conversion efficiency of Inari Medical Inc from 2018 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $464.91 Million | $35.93 Million | 0.077x | +330.64% |
| 2022-12-31 | $417.00 Million | $-13.97 Million | -0.034x | -131.45% |
| 2021-12-31 | $239.21 Million | $25.49 Million | 0.107x | +1015.88% |
| 2020-12-31 | $200.25 Million | $1.91 Million | 0.010x | -92.43% |
| 2019-12-31 | $-39.14 Million | $-4.94 Million | 0.126x | -54.33% |
| 2018-12-31 | $-39.45 Million | $-10.89 Million | 0.276x | -- |